Evaluating the Use of Two Different Needles in Subjects With Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

119 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-04-30

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is conducted in Europe. The aim of this trial is to compare two needle types when used with a disposable insulin injection pen in the everyday life setting of an insulin treated patient with diabetes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

NCT00872560

Diabetes Diabetes Mellitus, Type 1 Delivery Systems

COMPLETED PHASE3

Comparison of NovoFine® Needles (4 mm vs. 6 mm)

NCT00343343

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 +1 more

COMPLETED PHASE2

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

NCT00928057

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

COMPLETED NA

Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle

NCT01024218

Diabetes Healthcare Professionals Delivery Systems

COMPLETED PHASE4

Comparison of Glycemic Control Achieved With 2 Different Needles

NCT00572052

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 +1 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NovoFine® needle 6 mm

Intervention Type DEVICE

NovoFine® needle 8 mm

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed and dated informed consent obtained before any trial-related activities
* Diagnosed type 1 or type 2 diabetes
* Treated with insulin

Exclusion Criteria

* Previous participation in this trial
* Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation
* Any disease or condition which the investigator feels would interfere with the trial

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No